Anthrogen
PrivateLast Round
Seed
Nov 12, 2024
Total Funding Raised
$4.5M
Company Overview
Anthrogen is a bioengineering company that operates a platform to generate molecular machines for applications in human health, carbon capture, and industrial manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, ML Platforms, Medical AI
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anthrogen Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Anthrogen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 12, 2024 | ||||
| Pre Seed | Jun 7, 2024 |
Anthrogen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Fund | Seed |
| Ritual Capital | Seed |
| Wayfinder Ventures | Seed |
| Regenerative Ventures Holdings | Seed |
| Todd & Rahul Capital | Seed |
| Wayfinder Ventures | Seed |
| Ritual Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 23, 2025
Launched Odyssey, a 102B parameter model using Consensus and discrete diffusion.
- Nov 12, 2024
$4M raised in Seed round.
Anthrogen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Anthrogen's valuation, stock price, and market status.